| P2093 | author name string | A Goudeau | |
| | R K Selander | |
| | J M Musser | |
| | S J Mattingly | |
| | R Quentin | |
| P2860 | cites work | Evolutionary genetics of the encapsulated strains of Haemophilus influenzae | Q33657121 |
| | Growth of several cariogenic strains of oral streptococci in a chemically defined medium | Q34117303 |
| | Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence | Q34354121 |
| | Extracellular neuraminidase production by group B streptococci | Q34416854 |
| | Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci | Q34454327 |
| | Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern | Q36239022 |
| | Association of elevated levels of cellular lipoteichoic acids of group B streptococci with human neonatal disease | Q36346410 |
| | Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens | Q36358253 |
| | Correlation between the production of extracellular substances by type III group B streptococcal strains and virulence in a mouse model. | Q36430428 |
| | Factors influencing release of type III antigens by group B streptococci. | Q36442409 |
| | Methods of multilocus enzyme electrophoresis for bacterial population genetics and systematics | Q36665422 |
| | Clonal population structure of encapsulated Haemophilus influenzae. | Q36997732 |
| | Clonal diversity in Haemophilus pleuropneumoniae | Q37018756 |
| | Clonal analysis of Escherichia coli O2:K1 isolated from diseased humans and animals | Q37030815 |
| | Genetic diversity in relation to serotype in Escherichia coli | Q37050293 |
| | Kinetic and chemical analyses of the biologic significance of lipoteichoic acids in mediating adherence of serotype III group B streptococci | Q37052886 |
| | In vitro method to differentiate isolates of type III Streptococcus agalactiae from symptomatic and asymptomatic patients | Q37147074 |
| | Protease production by clinical isolates of type III group B streptococci. | Q37328631 |
| | Extracellular neuraminidase production by clinical isolates of group B streptococci from infected neonates. | Q37329956 |
| | The Emergence of Group B Streptococci in Infections of the Newborn Infant | Q39622423 |
| | Population genetics of pathogenic bacteria | Q39704129 |
| | Clonal analysis of descent and virulence among selected Escherichia coli | Q39747509 |
| | Group B streptococcal vaccines | Q39828266 |
| | The population genetics of Escherichia coli | Q40080341 |
| | Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis | Q40164208 |
| | Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci | Q40177945 |
| | Enzyme polymorphism and genetic population structure in Escherichia coli and Shigella | Q42665980 |
| | Epidemiological aspects of human/animal interrelationship in GBS. | Q43210506 |
| | The incidence of GBS disease in neonates in different countries. | Q46856864 |
| | Comparison of clonal analysis and DNA restriction analysis for typing of Neisseria meningitidis. | Q53044030 |
| | Summary of the Workshop on Perinatal Infections Due to Group B Streptococcus | Q66695784 |
| | Group B streptococcal carriage and disease: a 6-year prospective study | Q68923771 |
| | GBS enzymes, hemolysin, toxins and other products | Q69912223 |
| | The genetics of GBS | Q70103695 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Streptococcus agalactiae | Q132949 |
| P1104 | number of pages | 5 | |
| P304 | page(s) | 4731-4735 | |
| P577 | publication date | 1989-06-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease | |
| P478 | volume | 86 | |